Immunoadsorption in dilated cardiomyopathy: Long-term reduction of cardiodepressant antibodies

European Journal of Clinical Investigation

Volumn 40, Issue 8, 2010, Pages 685-691

  Trimpert, Christiane ^a   Herda, Lars R ^a   Eckerle, Lars G ^a   Pohle, Susanne ^a   Müller, Carina ^a   Landsberger, Martin ^a   Felix, Stephan B ^a   Staudt, Alexander ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Autoantibodies; dilated cardiomyopathy; immunoadsorption; negative inotropy; rat cardiomyocytes

Indexed keywords

AUTOANTIBODY; CALCIUM ION; IMMUNOGLOBULIN G;

ADULT; ANIMAL CELL; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN TISSUE; IMMUNOADSORPTION; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; AUTOANTIBODIES; CALCIUM; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; RATS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77954492538     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02314.x     Document Type: Article

References (30)

1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006 113 : 1807 1816.
2. Caforio AL, Mahon NJ, McKenna WJ. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity 2001 34 : 199 204.
3. Shmilovich H, Danon A, Binah O et al. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Int J Cardiol 2007 117 : 198 203.
4. Schulze K, Becker BF, Schauer R, Schultheiss HP. Antibodies to ADP-ATP carrier - an autoantigen in myocarditis and dilated cardiomyopathy - impair cardiac function. Circulation 1990 81 : 959 969.
5. Fu ML. Anti-M2 muscarinic receptor autoantibodies and idiopathic dilated cardiomyopathy. Int J Cardiol 1996 54 : 127 135.
6. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999 99 : 649 654.
7. Matsui S, Fu M. Characteristic distribution of circulating autoantibodies against G-protein coupled cardiovascular receptors in patients with idiopathic dilated and hypertrophic cardiomyopathy. Int J Cardiol 1996 54 : 143 147.
8. Latif N, Baker CS, Dunn MJ, Rose ML, Brady P, Yacoub MH. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol 1993 22 : 1378 1384.
9. Jahns R, Boivin V, Hein L et al. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004 113 : 1419 1429.
10. Nishimura H, Okazaki T, Tanaka Y et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001 291 : 319 322.
11. Okazaki T, Tanaka Y, Nishio R et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 2003 9 : 1477 1483.
12. Staudt A, Bohm M, Knebel F et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002 106 : 2448 2453.
13. Staudt A, Dorr M, Staudt Y et al. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption. Am Heart J 2005 150 : 729 736.
14. Staudt A, Hummel A, Ruppert J et al. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J 2006 152 (712 e1 6.
15. Staudt A, Schaper F, Stangl V et al. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 2001 103 : 2681 2686.
16. Staudt A, Staudt Y, Hummel A et al. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy. Ther Apher Dial 2006 10 : 42 8.
17. Felix SB, Staudt A, Landsberger M et al. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 2002 39 : 646 652. (Pubitemid 34158161)
18. Staudt A, Staudt Y, Dorr M et al. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol 2004 44 : 829 836.
19. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008 29 (19 2388 2442.
20. Mahrholdt H, Wagner A, Deluigi CC et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006 114 : 1581 1590.
21. Caforio AL, Goldman JH, Baig MK et al. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart 1997 77 : 62 7.
22. de Leeuw N, Melchers WJ, Ruiter DJ et al. Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy. J Clin Pathol 1999 52 : 739 743.
23. Osterziel KJ, Hassfeld S, Geier C, Perrot A. [Familial dilated cardiomyopathy]. Herz 2005 30 : 529 534.
24. Muller J, Wallukat G, Dandel M et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000 101 : 385 391.
25. Mobini R, Staudt A, Felix SB et al. Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 2003 20 : 345 350.
26. Staudt A, Eichler P, Trimpert C, Felix SB, Greinacher A. Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol 2007 49 : 1684 1692.
27. Baba A, Yoshikawa T, Iwata M et al. Antigen-specific effects of autoantibodies against sarcolemmal Na-K-ATPase pump in immunized cardiomyopathic rabbits. Int J Cardiol 2006 112 : 15 20.
28. Wallukat G, Fu HM, Matsui S, Hjalmarson A, Fu ML. Autoantibodies against M2 muscarinic receptors in patients with cardiomyopathy display non-desensitized agonist-like effects. Life Sci 1999 64 : 465 469.
29. Wallukat G, Wollenberger A, Morwinski R, Pitschner HF. Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 1995 27 : 397 406.
30. Staudt Y, Mobini R, Fu M, Felix SB, Kuhn JP, Staudt A. Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur J Pharmacol 2003 466 : 1 6.